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Abstract
In November of 2007 a human adenovirus (HAdV) was isolated from a bronchoalveolar lavage (BAL) sample recovered from
a biopsy of an AIDS patient who presented with fever, cough, tachycardia, and expiratory wheezes. To better understand
the isolated virus, the genome was sequenced and analyzed using bioinformatic and phylogenomic analysis. The results
suggest that this novel virus, which is provisionally named HAdV-D59, may have been created from multiple recombination
events. Specifically, the penton, hexon, and fiber genes have high nucleotide identity to HAdV-D19C, HAdV-D25, and HAdV-
D56, respectively. Serological results demonstrated that HAdV-D59 has a neutralization profile that is similar yet not
identical to that of HAdV-D25. Furthermore, we observed a two-fold difference between the ability of HAdV-D15 and HAdV-
D25 to be neutralized by reciprocal antiserum indicating that the two hexon proteins may be more similar in epitopic
conformation than previously assumed. In contrast, hexon loops 1 and 2 of HAdV-D15 and HAdV-D25 share 79.13 and 92.56
percent nucleotide identity, respectively. These data suggest that serology and genomics do not always correlate.
Citation: Liu EB, Wadford DA, Seto J, Vu M, Hudson NR, et al. (2012) Computational and Serologic Analysis of Novel and Known Viruses in Species Human
Adenovirus D in Which Serology and Genomics Do Not Correlate. PLoS ONE 7(3): e33212. doi:10.1371/journal.pone.0033212
Editor: Michael A. Barry, Mayo Clinic, United States of America
Received July 23, 2011; Accepted February 12, 2012; Published March 13, 2012
Copyright:  2012 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was financially supported by grant R01EY013124 (DWD, DS, MSJ and JC) and P30EY014104 (JC). LS, NRH, and MSJ were supported by
United States Air Force Surgeon General grant FDG20040024E. JC is also funded by an unrestricted grant to the Department of Ophthalmology, Harvard Medical
School, from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: drmorrisj@yahoo.com
. These authors contributed equally to this work.
Introduction
The first human adenoviruses (HAdVs) were isolated in 1953 from
a military basic trainee and the adenoid tissue of a pediatric patient as
respiratory pathogens [1]. Presently there are greater than 60 types
that have been isolated and characterized either with serological
methods or, more recently, genomic methods [2,3,4,5,6]. HAdVs are
classified into the Mastadenovirus genus and are further parsed into
seven species (A–G) [3,4,5,6,7,8]. Originally, HAdV types were
identified, characterized and classified based on serum neutralization
and hemagglutination inhibition assays among other biological
attributes [9]; however recently, bioinformatics and genomic analysis
of the whole genome have replaced serology-based methods for
typing novel HAdVs [3,4,5,6,8,10]. At the nucleotide level, the
members of each adenovirus species are highly similar to each other,
and do not commonly recombine with members of other species. The
species groupings, in part, may reflect the cell tropism of the viruses,
as well as the resulting symptoms and diseases caused by the
individual HAdV types. For example, species HAdV-B1 viruses are
known to cause respiratory infections of the lower lung [11] whereas
viruses in species HAdV-D can cause ocular disease, including
epidemic keratoconjunctivitis [12], and gastrointestinal disease [3,13].
In this report, an adenovirus isolated from a bronchoalveolar
lavage (BAL) sample that was biopsied from an AIDS patient who
presented with fever, cough, tachycardia and expiratory wheezes is
examined using genomics and bioinformatics. Based upon the
whole genome analysis and supported by limited serological data,
this adenovirus belongs to species HAdV-D, and is a ‘never seen
before’ novel virus, to be given the name of HAdV-D59.
Materials and Methods
Ethics Statement
The work reported herein was performed under United States
Air Force Surgeon General-approved Clinical Investigation
No. FDG20040024E, by the Institutional Review Board at the
David Grant USAF Medical Center. Informed Consent was not
required, because we did not use clinical samples.
Viruses, cells, and serum neutralization assay
Adenovirus neutralization assays were run as previously
described [14]. Briefly, serotyping of adenovirus isolates was
performed using a standard dose of virus against specific rabbit
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from the collection maintained by the Viral and Rickettsial
Disease Laboratory of the California Department of Public
Health, Richmond, CA. Reference viruses were originally
obtained from the reporting investigators: the Research Reference
Reagents Branch, National Institutes of Health; the Respiratory
Viral Disease Unit, Centers for Disease Control and Prevention;
or the American Type Culture Collection. Stock virus cultures
were passaged in A549 cells (American Type Culture Collection,
Rockville, MD), the cells were disrupted by vortexing, and cell-free
supernatant fluid was then frozen at 270uC.
Equal volumes of diluted virus and immune serum were mixed
and incubated for one hour in 5% CO2 at 37uC. Thereafter A549
cells were added, mixed, and incubated at 37uCi n5 %C O 2 for 7
days. Each assay contained a back titration of the virus used.
Living cells were distinguished from dead cells by measuring the
amount of Finter’s Neutral Red [15] present as indicated by
absorbance at 550 nm using a microplate spectrophotometer (Bio-
Tek Instruments, Winooski, VT). Virus neutralization titers were
determined by equating cell death to virus growth (no virus
neutralization). Neutralization was plotted as a percentage of cell
control absorbance, to determine endpoint virus and serum titers.
Three independent experiments were run yielding similar results.
Nucleotide sequence accession numbers
The HAdV-D59 genome sequence and its annotation are
deposited in GenBank and retrievable as accession number
JF799911. In addition, the following HAdV genomes (GenBank
accession numbers) were used for comparative computational
analyses: HAdV-D8 (AB448767), HAdV-D9 (AJ854486), HAdV-
D15 (AB562586), HAdV-D17 (AF108105), HAdV-D19C
(EF121005), HAdV-D22 (FJ404771), HAdV-D25 (unpublished),
HAdV-D26 (EF153474), HAdV-D28 (FJ824826), HAdV-D36
(GQ384080), HAdV-D37 (DQ900900), HAdV-D46 (AY875648),
HAdV-D48 (EF153473), HAdV-D49 (DQ393829), HAdV-D53
(FJ169625), HAdV-D54 (AB333801), HAdV-D56 (HM770721),
and HAdV-D58 (HQ883276).
Fiber coding sequences used for analysis were as follows:
HAdV-D8 (AB448767), HAdV-D9 (AJ854486), HAdV-D10
(AB369368), HAdV-D19C (AB448774), HAdV-D19a
(CS301726), HAdV-D22 (FJ619037), HAdV-D26 (EF153474),
HAdV-D28 (FJ824826), HAdV-D29 (AB562587), HAdV-D36
(GQ384080), HAdV-D37 (DQ900900), HAdV-D46 (AY875648),
HAdV-D48 (EF153473), HAdV-D49 (DQ393829), HAdV-D54
(AB333801), HAdV-D56 (HM770721), and HAdV-D58
(HQ883276). Fiber genes from species HAdV-D genomes were
aligned using ClustalW [16]. For this analysis, the default gap
opening and gap extension penalties were 15.0 and 6.66.
Amplification and DNA sequencing of the HAdV-D59
genome
To amplify regions of HAdV-D59 using the polymerase chain
reaction (PCR) protocol, conserved adenovirus sequences in
species HAdV-D were used to design primers. All amplicons were
then sequenced on an ABI 3130xl using a primer walking strategy.
The HAdV-D59 genome was sequenced to 8-fold coverage
following PCR amplification, with both strands represented.
Bioinformatics
The HAdV-D59 genome was compared against a select number
of viral genomes from the HAdV-D group based on its GC
content, which is indicative of HAdV species. The selection of
which genomes was based on initial overall high nucleotide
identity to HAdV-D59. The data presented are final iterations of
analyses that initially included all of the sequenced genomes in
species HAdV-D.
Recombination analysis
Whole genome sequences of HAdV-D59 and members of
species HAdV-D were first aligned with kalign (http://www.ebi.
ac.uk/Tools/msa/kalign/) for a broad perspective of the genome.
SimPlot [17] was then used to construct a Bootscan analysis of the
aligned sequences. The window size and step size were set to 1000
and 200 respectively.
Following this, to provide a detailed close inspection of
recombination events, the penton base gene, hexon gene, E3
coding region and fiber gene from the HAdV-D genomes were
aligned to their counterparts using ClustalW [16]. This was also
followed by recombination analysis using SimPlot with the window
size and step size set to 250 and 50, respectively.
Figure 1. Genome organization of HAdV-D59. The HAdV-D59 genome is represented by a black horizontal line marked at 5-kbp intervals.
Protein encoding regions are shown as arrows indicating transcriptional orientation above and below the genome. Spliced genes are indicated by V-
shaped lines.
doi:10.1371/journal.pone.0033212.g001
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Whole genome, penton base gene, hexon gene, E3 coding
region and fiber gene nucleotide sequences of HAdV-D59, along
with members of species HAdV-D, were aligned using kalign;
these were then compared to each other based on percent identity
values calculated with Chimera [18].
Phylogenomic analysis of HAdV-D59
Sequence alignments for phylogenomic analysis were generated
using the kalign method noted earlier. Phylogenetic trees were
constructed from these aligned sequences using Molecular Genetic
Analysis Software (MEGA 4.1; http://www.megasoftware.net), via
neighbor-joining methods and bootstrap test of phylogeny with
replicates set to 1000.
Results
Clinical Investigation
In November 2007, an AIDS patient was admitted to San
Francisco General Hospital, presenting with fever. The patient
also complained of a cough productive of yellow sputum and
blood. Clinical examination revealed a body temperature of
101uF, tachycardia and expiratory wheezes. During the hospital
stay, a CT scan displayed results suggestive of a cavitary lung
lesion. This prompted a bronchoalveolar lavage (BAL) for a
diagnostic specimen (via bronchoscopy). A virus was cultured from
the BAL sample and sent to the California Department of Public
Health (CDPH) for further analysis and identification. No other
pathogens were isolated from this patient.
The virus was propagated at the Viral and Rickettsial Disease
Laboratory at the California Department of Public Health, and
was identified as an unknown adenovirus by serum neutralization
assay. Initial sequence analysis of amplicons derived from the
hexon and the fiber genes revealed similarity to gene sequences
from HAdV-D25 and HAdV-D56, respectively. The possibility
that this virus might represent a novel, recombinant pathogen
provoked whole genome analysis in order to characterize this
isolate more thoroughly.
Amplification, sequencing, and genetic characteristics of
the novel adenovirus
To elucidate the genetic characteristics of this pathogen (HAdV-
D59), we sequenced and analyzed the entire genome. The genome
length of HAdV-D59 is 35,072 base pairs (Figure 1), with a base
composition of 22.4% A, 20.4% T, 28.5% G, 28.7% C. The GC
content of 57.2% is consistent with the values found for members
of species HAdV-D (mean of 57.0%). The organization of the 36
open reading frames (ORFs) that were annotated had a genome
organization similar to other mastadenoviruses (Fig. 1). The
inverted terminal repeat (ITR) sequences for HAdV-D59 were
determined to be 151 bp in length. Within species HAdV-D,
HAdV-D59 has a genome percent identity ranging from a low of
92.06% (HAdV-D8) to 96.48% (HAdV-D9).
Genome Analysis
Since initial DNA sequencing suggested evidence of recombi-
nation, we analyzed the HAdV-D59 genome using zPicture, a
dynamic blastz alignment visualization program designed for
comparative analysis (http://zpicture.dcode.org/). Comparisons
of the HAdV-D59 genome with the whole genome sequences of
HAdV-D9, -D22, -D19C, -D25, -D28, -D36, -D56 and -D58 were
performed. Consistent with other previously reported viruses in
species HAdV-D [4,19], HAdV-D59 shows heterogeneity in the
penton base, hexon, E3, and fiber coding sequences (Fig. 2A).
Pairwise alignment suggested that these regions had highest
nucleotide identities with sequences from HAdV-D9, HAdV-
D19C, HAdV-D25, HAdV-D28, and HAdV-D56 (Table 1).
Comprehensive phylogenomic analyses of whole genome
HAdVs were performed. Using sequences available in GenBank
as well as the unpublished sequence of HAdV-D25, the whole
genome phylogenetic tree analysis resulted in a subclade that
includes HAdV-D59, HAdV-D9, and HAdV-D56 with a high
confidence bootstrap value of 97 (Fig. 2B).
Penton Base Gene Analysis
Recently it was shown that two coding sequences for the
external hypervariable loops in the penton base gene contain
hotspots for recombination in species HAdV-D [20]. Analysis of
the primary amino acid sequences in species HAdV-D showed
that the most similar loop1 sequences (nucleotides 200–600) to that
of HAdV-D59 were HAdV-D28 and HAdV-D36 (80.95%). In
addition, the most similar RGD loop (nucleotides 650–1150) to
HAdV-D59 was HAdV-D22 with 100% amino acid identity.
Bootscan analysis [17] with penton base sequences from species
HAdV-D confirmed the aforementioned relationships (Fig. 3).
Phylogenetic analysis of the HAdV-D59 penton base hypervari-
able loop 1 also confirmed that it is a close relative of HAdV-D28
and HAdV-D36 with a robust bootstrap value of 91 (Fig. 3B).
Phylogenetic analysis also demonstrated that the HAdV-D59
Figure 2. Comparative genomic analysis. (A) Pairwise nucleotide comparison of selected HAdV-D genomes to HAdV-D59 using zPicture. The
arrows above the x-axis demarcate the positions of penton base, hexon, E3 region, and fiber coding sequences in the genome of HAdV-D59. The y-
axis notes the percent identity. HAdV-D9, HAdV-D22, HAdV-D19C, HAdV-D25, HAdV-D28, HAdV-D36, and HAdV-D56 were used for comparison to
HAdV-D59 because they share high nucleotide identity to the aforementioned virus in different sections of their genomes. (B) Whole genome
phylogenetic analysis. The phylogenetic tree was constructed from aligned sequences using MEGA, via the neighbor-joining methods and a
bootstrap test of phylogeny. Bootstrap values shown at the branching points indicate the percentages of 1000 replications produced the clade. A
Bootstrap value of 70 and above is considered to be robust.
doi:10.1371/journal.pone.0033212.g002
Table 1. Percent identities of the nucleotide coding
sequences of selected HAdV-D59 coding regions to
homologous sequences from other viruses in species HAdV-D.
Penton Hexon L1 Hexon L2 E3 Fiber
HAdV-D9 92.63% 79.14% 85.56% 96.35% 99.54%
HAdV-D15 93.03% 78.10% 91.48% 80.57% 77.45%
HAdV-D19C 93.03% 75.41% 88.89% 80.52% 76.59%
HAdV-D22 97.55% 78.23% 81.85% 83.02% 70.75%
HAdV-D25 92.64% 96.48% 95.91% 82.82% 71.06%
HAdV-D28 92.31% 77.44% 82.22% 77.61% 69.97%
HAdV-D36 93.60% 75.55% 75.19% 78.30% 69.89%
HAdV-D56 92.44% 78.23% 91.11% 95.98% 99.82%
HAdV-D58 92.63% 74.97% 77.29% 82.88% 70.61%
doi:10.1371/journal.pone.0033212.t001
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D19C and HAdV-D22 with a bootstrap value of 92 (Fig. 3C).
Hexon Gene Analysis
A previous study showed that recombination in HAdVs can
occur within the hexon gene of viruses in species HAdV-D [8].
This has also been demonstrated in other species of HAdVs [4,5].
To determine whether or not the HAdV-D59 hexon coding region
was either novel or the result of a recombination event, SimPlot
analysis was performed. SimPlot results were not consistent with a
recent recombination event in the hexon of HAdV-D59 (Fig. 4A).
In addition, the nucleotide percent identity to other hexon coding
sequences in species HAdV-D was determined (Table 1). HAdV-
D59 loops 1 and 2 (L1 and L2) were 96.48% and 95.19% identical
to L1 and L2 of HAdV-D25, respectively (Table 1). Phylogenetic
analysis demonstrated that L1 of HAdV-D59 and HAdV-D25 are
as distantly related as the following HAdV pairs which were shown
to be distinct via serology [21]: HAdV-D39 and HAdV-D43;
HAdV-D37 and HAdV-D13; HAdV-D15 and HAdV-D30;
HAdV-D29 and HAdV-D30; HAdV-D9 and HAdV-D32, as well
as HAdV-D45 and HAdV-D26 (Fig. 4B). Furthermore, the same
phenomenon was observed for L2 with the exception of the
HAdV-D45/D26 pair (Fig. 4C).
The difference in nucleotide identity between HAdV-D59 and
HAdV-D25 (the nearest phylogenetic relative to HAdV-D59) in
the L1 and L2 domains are greater than 2.5% (3.52% and 4.81%,
respectively). Madisch et al stated that percent nucleotide identity
differences greater than 2.4% and 2.5% in L1 and L2,
respectively, strongly suggests identification of a novel HAdV
[22]. Therefore the percent of nucleotide identity differences in L1
and L2 of HAdV-D59 further suggests that the aforementioned
virus is novel.
E3 Genome Region Analysis
SimPlot and Bootscan results suggest that a large portion of the
E3 transcription region (genes encoding for the CR1b, 18.4 k,
CR1c, RIDa, RIDb, and 14.7 k proteins) in HAdV-D59 may
have originated from a recombination event between either
HAdV-D56 or HAdV-D9 and another yet to be described HAdV
(Fig. 5). Interestingly, the SimPlot results suggest that a
recombination event took place within the open reading frame
of the CR1b gene (Fig. 5A). We also examined other E3 genes in
species HAdV-D and did not detect common recombination loci
(data not shown).
Phylogenetic analyses of two genes (CR1b and CR1c genes) in
the E3 region demonstrate that the coding regions for CR1b and
CR1c in HAdV-D59 are closely related to those of HAdV-D9 and
HAdV-D56 (Fig. 5B, 5C).
Fiber Gene Analysis
SimPlot analyses of the HAdV-D59 fiber was performed on
fiber sequences extracted from GenBank. The results suggested
that the fiber gene of HAdV-D59 is nearly identical with
sequences from both HAdV-D56 and HAdV-D9 (Fig. 5A).
Furthermore, the fiber of HAdV-D59 had 99.54% and 99.84%
nucleotide identities with HAdV-D9 and HAdV-D56 (Table 1),
respectively. Phylogenetic analysis of the fiber genes in species
HAdV-D confirms that the fiber of HAdV-D59 was closest in
sequence to the corresponding sequences in HAdV-D56 and
HAdV-D9 (Fig. 5D).
Serum Neutralization
HAdV-D59 was neutralized by both HAdV-D25 and HAdV-
D15 antiserum, yet not by HAdV-D9 antiserum (Table 2).
Interestingly, HAdV-D25 antiserum showed at least a two-fold
higher neutralization titer to HAdV-D59 (greater than 1:4096)
than it did against its cognate antigen HAdV-D25 (1:2048)
(Table 2). These results demonstrate that the antigenic profile of
HAdV-D59 differs from that of HAdV-D25 (Table 2). HAdV-D15
antiserum demonstrated only a two-fold increase in its ability to
neutralize its cognate HAdV-D15 (1:1024) relative to the
heterologous HAdV-D25 antigen (1:512). Similar reciprocal
results were obtained with HAdV-D25 antiserum against
HAdV-D15 (1:1024) and HAdV-D25 (1:2048). When tested with
rabbit serum our results indicate that HAdV-D15 and HAdV-D25
are not as serologically distinct as previously reported [21].
Discussion
Our results demonstrated that HAdV-D25 antiserum was more
effective at neutralizing HAdV-D59 than HAdV-D25 (Table 2).
Since L1 and L2 protrude from the surface of HAdVs [23], it is
not surprising that there is a difference between the ability of
HAdV-D25 antiserum to neutralize the different viruses. One
possibility for the differences in neutralization may be that the few
differences in the primary amino acid structure present the HAdV-
D59 hexon three-dimensional structure in such a way that the
neutralizing epitopes are enhanced, thus making the virus easier to
neutralize. Interestingly, we also observed a two-fold difference
between the ability of HAdV-D15 and HAdV-D25 to be
neutralized by reciprocal antiserum. This contradicts one study
that showed antiserum to HAdV-D15 and HAdV-D25 did not
cross-react in reciprocal neutralization experiments [21]. Howev-
er, our data are consistent with the original characterization of
HAdV-D15 and HAdV-D25 (previously called BP-1) [24], thus we
conclude that HAdV-D15 and HAdV-D25 are not separate
serotypes according to the traditional methods used for differen-
tiating serotypes. These results also demonstrate that using
neutralization as a criterion to type novel adenoviruses is
complicated by non-standard serology methods and reagents that
may yield interlaboratory variability of neutralization results. In
contrast, using genomics as a method for typing HAdVs is
consistent regardless of which laboratory generates the results.
Even though HAdV-D15 and HAdV-D25 showed only a two-
fold difference via serum neutralization, they were recognized as
different serotypes by Rosen et al, because they had different fiber
proteins [24]. HAdV-D15 and HAdV-D25 share 79.13 and 92.56
percent nucleotide identity in L1 and L2, respectively. Thus,
bioinformatic analysis demonstrates that they are actually different
types using the criteria established by Madisch et al. which states
that the nucleotide identity of L2 must differ by greater than 2.5
percent to type a novel virus [22]. Furthermore, pairwise
nucleotide comparison of the hexon coding sequences for
HAdV-D15 and HAdV-D25 show how genetically divergent they
are (Fig. 6). Neutralization assays measure the overall effect of
various antibodies that bind to multiple epitopes and may yield
Figure 3. Computational analysis of the penton base gene. (A) Bootscan analysis of the HAdV-D59 penton base gene with fully sequenced
penton genes in species HAdV-D using a window size of 250 bp and step size of 50 bp. (B) Phylogenetic analysis of the hypervariable loop 1 penton
base gene sequences in species HAdV-D. (C) Phylogenetic analysis of the RGD motif and surrounding variable region of sequences in species HAdV-D.
The phylogenetic trees were generated from aligned sequences using MEGA, via the neighbor-joining method and a bootstrap test of phylogeny.
doi:10.1371/journal.pone.0033212.g003
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loops 1 and 2 of the hexon gene, which comprise the determinant of virus serum neutralization. (B) Phylogenetic analysis of the hexon L1 sequences
in species HAdV-D. (C) Phylogenetic analysis of the hexon L2 sequences in species HAdV-D. A phylogenetic tree was generated along with
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and a bootstrap test of phylogeny.
doi:10.1371/journal.pone.0033212.g004
Figure 5. Computational analysis of the E3 and Fiber regions. (A) SimPlot analysis of the E3 and fiber region of HAdV-D59 compared to fully
sequenced E3 and fiber regions from species HAdV-D. The arrows over the Bootscan demarcate the approximate positions of the E3 coding
sequences. Phylogenetic analysis of (B) HAdV-D59 CR1b (C) HAdV-D59 CR1c, and (D) fiber knob. The phylogenetic trees were generated from aligned
sequences using MEGA, via the neighbor-joining method and a bootstrap test of phylogeny.
doi:10.1371/journal.pone.0033212.g005
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reagents. Genomic analyses measure genetic differences in the
genome that have the potential to affect the pathogenicity of the
virus and can be independently verified by most laboratories. The
contrasting serology and genomics results for HAdV-D15 and
HAdV-D25 demonstrate that these two methods do not always
yield concordant results.
SimPlot analysis of the HAdV-D59 L1 and L2 regions
demonstrates high nucleotide identity between the hexons of
HAdV-D25 and HAdV-D59 and suggests that they may be
derived from a yet undiscovered common ancestor. If L1 and L2
of HAdV-D25 and HAdV-D59 are from a common ancestor, the
recombination event may be ancient, as evidenced by 3.52 and
4.81 percent nucleotide differences in the L1 and L2 sequences,
respectively. If the recombination events were recent, SimPlot
analysis would illustrate near 100% nucleotide identity, which was
shown for HAdV-D53 and HAdV-D56 [4,5,19] With a distant
past recombination event the hexon genes from HAdV-D25 and
HAdV-D59 would have mutated over many replication cycles,
after the initial recombination, to result in the variation we
detected.
Multiple studies have shown that HAdVs in species HAdV-D
recombine with one another in the penton base and hexon genes
[4,8,20]. In this paper, we demonstrate that recombination may
have occurred in the E3 region of HAdV-D59; however, after
examining all of the sequenced E3 genes in species HAdV-D, we
found that there was not a predictable pattern of recombination
(data not shown). Viruses in species HAdV-D show variability in
their cell tropism ranging from growth in ocular tissues to
gastrointestinal and/or respiratory tissues [4,25,26]. Given that
the fiber knob is an important determinant of cell tropism, it may
be concluded that recombination is an important molecular
evolution pathway for the diversity observed within species HAdV-
D.
The section of the HAdV-D59, -D56, and –D9 genomes that
encodes for CR1b, CR1c, RIDa, RIDb, 14.7K, and fiber show
high nucleotide identity (Fig. 5A). From the nucleotide data, it is
impossible to tell whether or not the 39 end of HAdV-D59 came
from HAdV-D56 or HAdV-D9. Although HAdV-D9 was
discovered in 1957 [25], there has been no disease associated
with this virus. In contrast, prior serological evidence suggests that
HAdV-D56, an ocular and respiratory pathogen (with hexon and
fiber coding sequences similar to HAdV-D15 and HAdV-D9,
respectively) [12,26] has been implicated in human disease as
early as 1960 [27] and at other points in time as well
[27,28,29,30,31,32]. HAdV-D59 may have also existed prior to
our current description yet had gone undetected during the same
time periods. Thus, it is impossible to say with absolute certainty
which of the aforementioned viruses existed first and/or whether
they evolved from a common ancestor. Future genomic analysis of
known and unknown adenoviruses is needed to elucidate further
the evolutionary history of HAdVs.
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